Acute management of anaphylaxis in pregnancy.
Autor: | Tan E; MBBS (Hons), BSc, Clinical Immunology and Immunopathology Advanced Trainee, Immunology Department, Fiona Stanley Hospital, Murdoch, WA., O'Sullivan M; MBBS, FRACP, FRCPA, Consultant Clinical Immunologist and Immunopathologist, Immunology Department, Fiona Stanley Hospital, Murdoch, WA; Immunology Department, Perth Children@s Hospital, Nedlands, WA; Clinical Senior Lecturer, Medical School, University of Western Australia, Perth, WA., Crozier T; MBBS (Hons), FRACP, FCICM, PGCertClinUS, MPH, Intensivist, Intensive Care Unit, Monash Medical Centre, Monash Health, Vic; Department of Intensive Care Services, Eastern Health, Vic; Adjunct Senior Lecturer, Monash University, Vic., Kolawole H; BMedSc, MBBS, MClinEd, FANZCA, Specialist Anaesthetist, Department of Anaesthesia and Perioperative Medicine, Monash University, Vic; Department of Anaesthesia, Peninsula Health, Frankston, Vic., Mantas S; BPharm (Hons), Senior Pharmacist, Allergies and HIV Services, Pharmacy Department, Monash Health, Vic., Said M; RN, CEO, Allergy @ Anaphylaxis Australia, NSW; Co-chair, National Allergy Strategy, NSW., Rueter K; MD, FRACP, PEM, Consultant Clinical Immunologist, Consultant Emergency Physician, Emergency Department and Department of Immunology, Perth Children@s Hospital, Nedlands WA; School of Medicine, the University of Western Australia, Crawley, WA., Frith K; MBBS, FRACP, MRCPCH, Consultant Clinical Paediatric Immunologist, Department of Immunology and Infectious Diseases, Sydney Children@s Hospital, Sydney, NSW; School of Women@s and Children@s Health, University of New South Wales, Sydney, NSW., Barnes S; MBBS (Hons), MBA, FRACP, Adjunct Associated Professor, Monash University, Vic; Allergist/Immunologist, Monash Lung Sleep Allergy and Immunology, Monash Health, Vic. |
---|---|
Jazyk: | angličtina |
Zdroj: | Australian journal of general practice [Aust J Gen Pract] 2022 Jun; Vol. 51 (6), pp. 405-408. |
DOI: | 10.31128/AJGP-03-21-5918 |
Abstrakt: | Background: Anaphylaxis in pregnancy is rare but can potentially be associated with significant morbidity and mortality for the mother, fetus and neonate. With appropriate and timely management, even severe anaphylaxis can be managed with excellent maternal and fetal outcomes. Objective: The aim of this article is to provide an illustrative case and highlight current recommendations for diagnosis and management of acute maternal anaphylaxis, which have recently been reviewed and developed into a guideline by the Australasian Society of Clinical Immunology and Allergy. Discussion: An understanding of management of anaphylaxis in pregnancy is essential knowledge in the general practice setting. The recommended dosage and administration of adrenaline (epinephrine) for anaphylaxis is the same in pregnant and non-pregnant patients: 0.5 mg adrenaline intramuscularly in the mid-outer thigh (or dose of 0.01 mg/kg if <50 kg). The use of adrenaline in maternal anaphylaxis is supported by various international guidelines. |
Databáze: | MEDLINE |
Externí odkaz: |